Medpace (MEDP)
(Delayed Data from NSDQ)
$389.77 USD
-7.79 (-1.96%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $389.64 -0.13 (-0.03%) 7:58 PM ET
1-Strong Buy of 5 1
D Value A Growth A Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 7/22/24 |
---|---|
Current Quarter | 2.55 |
EPS Last Quarter | 3.20 |
Last EPS Surprise | 30.61% |
ABR | 1.33 |
Earnings ESP
|
-0.36% |
---|---|
Current Year | 11.23 |
Next Year | 13.03 |
EPS (TTM) | 9.81 |
P/E (F1) | 35.42 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 531.73M | 557.28M | 2.17B | 2.51B |
# of Estimates | 3 | 3 | 3 | 3 |
High Estimate | 535.10M | 561.45M | 2.19B | 2.56B |
Low Estimate | 530.00M | 554.40M | 2.16B | 2.45B |
Year ago Sales | 460.87M | 492.50M | 1.89B | 2.17B |
Year over Year Growth Est. | 15.38% | 13.15% | 15.30% | 15.23% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.55 | 2.71 | 11.23 | 13.03 |
# of Estimates | 3 | 3 | 3 | 3 |
Most Recent Consensus | 2.57 | 2.69 | 10.55 | 12.78 |
High Estimate | 2.59 | 2.77 | 11.41 | 13.45 |
Low Estimate | 2.49 | 2.66 | 11.07 | 12.77 |
Year ago EPS | 1.93 | 2.22 | 8.88 | 11.23 |
Year over Year Growth Est. | 32.12% | 22.07% | 26.46% | 16.06% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 0 | 3 | 2 |
Up Last 30 Days | 1 | 0 | 3 | 2 |
Up Last 60 Days | 0 | 0 | 2 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 2.55 | 2.71 | 11.23 | 13.03 |
7 Days Ago | 2.53 | 2.67 | 10.53 | 12.73 |
30 Days Ago | 2.53 | 2.67 | 10.53 | 12.73 |
60 Days Ago | 2.57 | 2.69 | 10.58 | 12.71 |
90 Days Ago | 2.41 | 2.50 | 10.05 | 12.31 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 2.54 | 2.77 | 11.23 | 13.16 |
Zacks Consensus Estimate | 2.55 | 2.71 | 11.23 | 13.03 |
Earnings ESP | -0.36% | 2.36% | 0.00% | 1.01% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 3.20 | 2.46 | 2.22 | 1.93 | NA |
Estimate | 2.45 | 2.23 | 2.04 | 1.90 | NA |
Difference | 0.75 | 0.23 | 0.18 | 0.03 | 0.30 |
Surprise | 30.61% | 10.31% | 8.82% | 1.58% | 12.83% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more